Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) improve glycemic control by increasing glucose-dependent insulin secretion, suppressing glucagon release, delaying gastric emptying, and inducing weight loss
A phase 2, randomized, dose-finding study of the novel once-weekly human glp-1 analog, semaglutide, compared with placebo and open-label liraglutide in patients with type 2 diabetes
CrossRef Non-Transplantable Recurrence After Initial Liver Resection of Hepatocellular Carcinoma: A Narrative Review Dima Malkawi, Ioannis A
Broader Health Implications & New Indications: Quantifying the cardiovascular and renal benefits in non-diabetic individuals using it solely for weight management is important
US$ 28.95
US$ 25.64
US$ 24.50
US$ 24.54
US$ 20.51
US$ 27.87
